The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders
Open accessAbstract
Background Opioid analgesics and other psychoactive drugs may pose an even greater risk for drug overdose in persons with mental health disorders.Objective The purpose of this study was to examine interactions of filled prescriptions for opioids, benzodiazepines, antidepressants, and zolpidem with mental health disorders in regard to drug overdose.Design The study was a retrospective cohort review.Subjects Subjects were national HMO beneficiaries aged 18-64 years, enrolled at least 1 year (01/2009 to 07/2012), who filled at least two prescriptions for Schedule II or III opioids for non-cancer pain.Main measures The outcome was the first inpatient or outpatient drug overdose after the first filled opioid prescription. Predictors were calculated in 6-month intervals and exactly 6 months before a drug overdose: opioid use (mean daily morphine-equivalent dose), benzodiazepine use (days' supply), antidepressant use (days' supply), zolpidem use (days' supply), mental health disorders (depression, anxiety/PTSD, psychosis), pain-related conditions, and substance use disorders (alcohol, other drug).Key results A total of 1,385 (0.67%) subjects experienced a drug overdose (incidence rate 421/100,000 person-years). The adjusted odds ratios (AOR) for overdose among all subjects rose monotonically with daily opioid dose, but highest (AOR = 7.06) for persons with depression and a high opioid dose (≥100 mg) versus no depression or opioid use. Longer-term antidepressants (91-180 days) were protective for persons with depression, with 20% lower AORs for overdose versus short-term (1-30 days) or none. For persons without depression, the AORs of overdose were increased for antidepressant use, but greatest (AOR = 1.98) for short-term use versus none. The AORs of overdose increased with the duration of benzodiazepine therapy among all subjects, with over 2.5-fold higher AORs for 91-180 days versus none.Conclusions Opioids and longer-duration benzodiazepines were associated with drug overdose among all subjects, but opioid risk was greatest for persons with depression. Antidepressant use > 90 days reduced the odds of overdose for persons with depression, but all antidepressant use increased the risk for persons without depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Over reliance on the use of prescription opioids as a frontline treatment for chronic pain contributed to a national epidemic including increased rates of opioid addiction, accidental overdose, and even mortality [16–20].”
From Benchmark findings from a veteran electronic patient-reported outcomes evaluation from a chronic pain management telehealth program (2024) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression and Pain Comorbidity: A Literature Review
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2433 · Cited by 3,463
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509
Opioid Prescriptions for Chronic Pain and Overdose
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta‐Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,265
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Foley, K. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130205 · Cited by 973
Pharmaceutical Overdose Deaths, United States, 2010
Jones, C. M., Mack, K. A., & Paulozzi, L. J. (2013) · JAMA · doi:10.1001/jama.2013.272 · Cited by 678
CDC grand rounds: prescription drug overdoses - a U.S. epidemic.
(2012) · PubMed · Cited by 494
Calcaterra, S., Glanz, J., & Binswanger, I. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.018 · Cited by 330 · cited 3×
“The combination of prescribed opioids and benzodiazepines is themost common cause of polysubstance overdose deaths nationally.(1) Persons withmental health disorders are more likely to be treated for chronic pain with high-dose opioid therapy that has also been associated with more coprescribed sedative-hypnotic thera…”
InfluentialAn analysis of the root causes for opioid-related overdose deaths in the United States
Webster, L. R., Cochella, S., Dasgupta, N., Fakata, K. L., Fine, P. G., Fishman, S. M., Grey, T., Johnson, E. M., Lee, L. K., Passik, S. D., et al. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01134.x · Cited by 295
Pain and the onset of depressive and anxiety disorders
Gerrits, M. M. J. G., van Oppen, P., van Marwijk, H., Penninx, B. W. J. H., & van der Horst, H. E. (2013) · Pain · doi:10.1016/j.pain.2013.09.005 · Cited by 242
Cited by
Sorted by citations
Items 101–109 of 109
Epidemiology: Opioid Use and Related Disorders
Binswanger, I. A., Glanz, J. M., & Ford, M. A. (2019) · Current clinical psychiatry · doi:10.1007/978-3-030-16257-3_2
Fik, V. B., & Paltov, Y. V. (2020) · World Science · doi:10.31435/rsglobal_ws/30092020/7163
TEMPORAL ANALYSIS OF THE PREVALENCE OF OSTEOARTICULAR PAIN AND MENTAL HEALTH
Marques, M. A. A., de Oliveira, B. G., Corsini, A. R., Filho, C. A. D. M., Resident Doctor Psiquiatria Pela Secretária Municipal De Saúde De Vitória Da Conquista, B., Peixoto, P. P. D. A., Holtz, F. N., Nerys, R. C., da Silva, L. C. P., & Simões, M. R. C. (2023) · The American Journal of Medical Sciences and Pharmaceutical Research · doi:10.37547/tajmspr/volume05issue11-05
Managing Pain in Patients on Long-Term Opioids
Sandbrink, F. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197649176.003.0031
Sani, A. R. A., & Zin, C. S. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2387602
Characteristics and predictors of prescription sleep medication use among veterans with chronic pain
Li, Y. I., Chen, C., Michel, M., Donovan, L. M., Zeliadt, S. B., & Chen, J. A. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001264
Haun, J. N., Fowler, C. A., Smith, B., Cao, L., Stroupe, K. T., Lapcevic, W. A., Saenger, M. S., Benzinger, R. C., & French, D. D. (2024) · Figshare · doi:10.6084/m9.figshare.26698976
Odoeke, M. C., Irorere, O., Omotunde, O., Osias, K., Bonhomme, M. R., Okwuokei, E., Madubuike, I. C., Nwaokobia, E. C., & Akinboboye, A. C. (2026) · Cureus · doi:10.7759/cureus.108951
Yarborough, B. J. H., Smith, N., Stumbo, S. P., Janoff, S. L., Keast, E. M., Wartko, P. D., Yeung, K., Zhu, W., Petronis, K. R., Ahmedani, B. K., et al. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113385
Metadata
- Authors
- Turner, B. J., & Liang, Y.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Turner, Barbara J.
- Venue
- Journal of General Internal Medicine
- Published
- 2015-02-04
- Volume
- 30
- Issue
- 8
- Pages
- 1081-1096
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- PMC
- PMC4510211
- OpenAlex
- W1992700677
- Cited by
- 109
- References
- 29
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 13 · 2018: 17 · 2017: 14 · 2016: 11 · 2015: 3
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of General Internal Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR001120)
- University of Texas Health Science Center at San Antonio
- National Center for Research Resources
- National Center for Advancing Translational Sciences (1UL TR001120)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug overdose, opioid analgesics, benzodiazepines, antidepressants, zolpidem, sedative-hypnotic drugs, mental illness, depression, opioid dose, substance use disorders, non-cancer pain, prescription drug misuse, benzodiazepine prescribing
- MeSH terms
- Zolpidem, Adolescent, Adult, Analgesics, Opioid, Antidepressive Agents, Mental Disorders, Benzodiazepines, Female, Humans, Hypnotics and Sedatives, Male, Middle Aged, Pain, Pyridines, Retrospective Studies, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
